Ardent Health board reclassifies former CEO Bonick’s termination as for cause
ARDT•Ardent Health’s board determined on October 19, 2026, that former CEO Martin J. Bonick’s departure warranted termination for cause, effective June 2. The company will stop remaining severance and benefits, including about $4.5 million in unpaid cash severance, and cancel or forfeit his unvested performance-based restricted stock units.
1. Termination reclassified
Ardent Health’s board determined that former CEO Martin J. Bonick’s departure warranted termination for cause, effective June 2, 2026. The board cited his failure to fully disclose third-party compensation required under company policies.
2. Severance and awards
Remaining severance payments and benefits will stop, including approximately $4.5 million in unpaid cash severance. All outstanding unvested performance-based restricted stock units will be canceled or forfeited.
